Selected publication milestones, not an exhaustive history or discovery priority claim.
1976 — 1976 Dutch induction natural experiment maps opposite obesity directions by prenatal/infant exposure window. Original PMID934222.
1991 — 1991 recorded birth/infant growth predicts late-adult glucose impairment; exposure causality remains unresolved. Original PMID1954451.
1997 — 1997 Leningrad null adult glucose/BP/lipid comparisons challenge uniform famine programming. Original PMID9402775.
2000 — 2000 maternal-diabetes discordant siblings and paternal controls test a human intrauterine contribution. Original PMID11118027.
2005 May 28-Jun 3 — 2005 randomized antenatal betamethasone thirty-year follow-up separates metabolic markers from clinical nulls. Original PMID15924982.
2014 — 2014 prenatal/postnatal cross-fostering demonstrates adult BP reversibility and distinct nursing effects. Original PMID24740990.
2019 — 2019 original maternal/fetal genetics separates transmission from an assumed intrauterine BP pathway. Original PMID31043758.
2024 — 2024 original BMI-polygenic selection analysis narrows one famine-cohort bias mechanism; it does not exclude every selection process. Original PMID39358993.
2024 — 2024 calcium-trial follow-up maps female-specific late-adolescent systolic BP effects, with multiplicity limits. Original PMID38839195.
Separate measured fetal exposure from birthweight as a mixed genetic and environmental proxy.
Triangulate non-genetic mortality/fertility selection; a null BMI polygenic-index comparison excludes only a measured genetic-selection explanation.
Do not infer nutrition-specific mediation from birthweight MR or cohort hazard ratios.
Identify selective developmental mediators with loss/rescue, including maternal food-intake and stress controls for steroid models.
Adult clinical follow-up must distinguish persistent susceptibility from accelerated deterioration and from childhood biomarkers.
Postnatal rescue and sex/window differences need prespecified replication rather than responder-defined narrowing.
Follow a prospectively defined prenatal exposure intervention or credible policy natural experiment into adult incident disease, with fetal/maternal genotype and sibling/paternal controls, prespecified sex/window contrasts, quantified postnatal nutrition and selection. Pair it with cross-species prenatal mediator loss and selective rescue while matching maternal intake, stress and lactation. Retain all enrolled exposure groups and telemetry/function outcomes rather than selecting responders or counting epigenetic marks as clinical proof.